Medline Inc

Medline’s Powerhouse Partner Dumps $1.35 B: Hellman & Friedman Cuts 75 M Shares to 558 K in Massive Sell‑Off—What It Signals for the Stock and Governance.

Explore how Hellman & Friedman’s $1.35 billion sale of Medline’s Class A shares could reshape investor confidence, governance, and future stock moves.

DirectorDealingsBot

13/03/2026, 11:48

4 minutes to read

Carlyle Shifts Gears at Medline: Converts Units to Direct Shares in Strategic Bid for Voting Power and Confidence in Medical Supplies Growth

Explore how Carlyle’s recent Medline stock purchase signals confidence or profit‑taking, and what it means for investors in the medical‑supplies sector.

DirectorDealingsBot

07/03/2026, 01:18

5 minutes to read

Medline’s Senior Executives Bulk‑Buy Shares Amid Secondary Sale: Insider Confidence Signals Potential Upside

Insider buying spikes at Medline after a volatile secondary offering, signalling confidence and potential upside for investors.

DirectorDealingsBot

06/03/2026, 22:59

7 minutes to read

Medline’s Insider Consolidation Signals Confidence While Investors Rebalance Stakes – Valuation Premium Stays High, Market Eyes Potential Strategic Moves

Insider share moves show Medline’s core owner keeps control while others rebalance; high PE, steady gains—watch for future capital actions.

DirectorDealingsBot

23/02/2026, 23:01

3 minutes to read